MLchartDataset catalogue

Patent · US12133965B2 · B2 · US

Injection system and day set assembly therefor

(11) Publication number
US12133965B2
(21) Application number
17/262,451
(22) Filing date
2019-07-23
(30) Priority date
2018-07-25
(43) Publication date
2024-11-05
(45) Date of grant
2024-11-05
(51) IPC
A61M 39/10; A61M 5/00; A61M 5/14; A61M 5/142; A61M 1/14
(52) CPC
  • A61M Devices for introducing media into, or onto, the body; devices for transducing body media or for taking media from the body; devices for producing or ending sleep or stupor {}: 5/14228, 2039/0009, 2039/0027, 2039/1016, 2205/50, 2205/502, 39/10, 39/1011, 39/105, 5/007, 5/1407, 5/1408, 5/1413, 5/1418
(73) Assignee
ACIST Medical Systems Inc
(72) Inventors
Pierre-Yves Chassot; Francois VULLIET
(54) Title
Injection system and day set assembly therefor
(57) Abstract

A solution for injecting one or more fluids into a patient is proposed. A corresponding injection system comprises: at least one supply station for supplying a fluid to be injected into a patient's vasculature: a pressurizing unit comprising a motor for pressurizing the fluid received from said at least one supply station: a delivery arrangement in fluid communication with said at least one supply station, the delivery arrangement comprising a connector having a connecting element and a latching mechanism: a patient set assembly in fluid communication with said delivery arrangement, said patient set assembly comprising a peristaltic pump component and at least one delivery tube for delivering the pressurized fluid to the patient, said peristaltic pump component having a connecting element for fluidically engaging the connecting element of the connector of the delivery arrangement at said port of the pressurizing unit, characterized in that said latching mechanism comprises an elongated flap integral with said connector, and said latching mechanism engages a corresponding port of the pressurizing unit.

Full text
View on Google Patents

Claims (15)

  1. An injection system (100) comprising: at least one supply station (105 a; 105 b; 105 c) for supplying a fluid to be injected into a patient's vasculature; a pressurizing unit (140) comprising a motor for pressurizing the fluid received from said at least one supply station (105 a; 105 b; 105 c); a delivery arrangement (135) in fluid communication with said at least one supply station (105 a; 105 b; 105 c), the delivery arrangement (135) comprising a connector (300) having a connecting element (375) and a latching mechanism (380); a patient set assembly (145) in fluid communication with said delivery arrangement (135), said patient set assembly (145) comprising a peristaltic pump component (147) and at least one delivery tube (146) for delivering the pressurized fluid to the patient, said peristaltic pump component (147) having a connecting element (150) for fluidically engaging the connecting element (375) of the connector (300) of the delivery arrangement (135) at a port (151) of the pressurizing unit (140), characterized in that said latching mechanism (380) comprises an elongated flap (381) integral with a connector body portion (370) of said connector (300), and said latching mechanism (380) engages a corresponding port (151) of the pressurizing unit (140).
  2. The injection system (100) according to claim 1, characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383).
  3. The injection system (100) according to claim 2, characterized in that the elongated flap (381) comprises a bulge element (386) protruding from an external profile of said second curvilinear portion (383).
  4. The injection system (100) according to claim 1, characterized in that the elongated flap (381) comprises a free first end (384) for being acted upon by an operator.
  5. The injection system (100) according to claim 4, characterized in that the elongated flap (381) comprises a second end (385), opposite to the first end (384), said second end (385) being integral with the connector body portion (370) of said connector (300).
  6. The injection system (100) according to claim 5, characterized in that the connector body portion (370) defines a front wall (371) and a rear wall (372), the second end (385) of the elongated flap (381) being integral with said rear wall (372).
  7. The injection system (100) according to claim 6, characterized in that the connector (300) comprises a housing (400) for receiving at least one tube of the delivery arrangement (135), said housing (400) being integral with the connector body portion (370).
  8. The injection system (100) according to claim 7, characterized in that the housing (400) is integral with the rear wall (372) of the connector body portion (370).
  9. The injection system (100) according to claim 7, characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383) and characterized in that a curvature of the second curvilinear portion (383) at least partially matches a curvature of the housing (400).
  10. The injection system (100) according to claim 7, characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383) and characterized in that the second curvilinear portion (383) is spaced apart from the housing (400).
  11. The injection system (100) according to claim 5, characterized in that the connector body portion (370) defines a front wall (371) and a rear wall (372) and characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383) and characterized in that the elongated flap (381) comprises a bulge element (386) protruding from an external profile of said second curvilinear portion (383) and characterized in that a first point (387) from which said bulge element (386) is originated is positioned at a different level with respect to a second point (388) where the second end (385) of the elongated flap (381) is attached to the rear wall (372) of the connector body portion (370).
  12. The injection system (100) according to claim 11, characterized in that, with reference to a base component (373) of the connector body portion (370), said first point (387) is positioned at a height greater than a height of said second point (388).
  13. The injection system (100) according to claim 4, characterized in that, in proximity of said free first end (384), an outer profile of said elongated flap (381) is provided with a gripping surface (389).
  14. The injection system (100) according to claim 1, characterized in that the delivery arrangement (135) comprises at least one supporting element (600) which is made of a single component and which has a substantially U-shape configuration in cross-section.
  15. The injection system (100) according to claim 1, characterized in that the connector (300) comprises a housing (400) for receiving at least one tube of the delivery arrangement (135), said housing (400) being integral with the connector body portion (370).

Description

The present disclosure relates to the field of medical devices. More specifically, the present disclosure relates to injection systems for delivering a medical fluid to a patient.

The background of the present disclosure is hereinafter introduced with the discussion of techniques relating to its context. However, even when this discussion refers to documents, acts, artifacts and the like, it does not suggest or represent that the discussed techniques are part of the prior art or are common general knowledge in the field relevant to the present disclosure.

The injection of fluids into patients is commonplace in several medical procedures. For example, a contrast agent (or contrast medium) may be injected, possibly along with a saline solution, to enhance contrast of target (body) features (for example, human body's structures or organs) within the patients in scan examinations thereof. Particularly, in imaging applications (wherein a visual representation of the interior of the patients is created in a non-invasive way without turning to surgery techniques) the use of the contrast agent makes the target features more conspicuous. As a result, target features that would otherwise be less distinguishable from other nearby features (for example, surrounding tissues) are highlighted. This significantly facilitates the task of clinicians in diagnostic applications, and particularly the identification and/or characterization of lesions, the monitoring of their evolution or response to medical treatments.

Citations (5)

  • US20090105629A1
  • US20150209515A1
  • US20140208251A1
  • US20150174320A1
  • US20160331891A1
Record as JSON
{
  "publication_number": "US12133965B2",
  "country": "US",
  "kind": "B2",
  "title": "Injection system and day set assembly therefor",
  "abstract": "A solution for injecting one or more fluids into a patient is proposed. A corresponding injection system comprises: at least one supply station for supplying a fluid to be injected into a patient's vasculature: a pressurizing unit comprising a motor for pressurizing the fluid received from said at least one supply station: a delivery arrangement in fluid communication with said at least one supply station, the delivery arrangement comprising a connector having a connecting element and a latching mechanism: a patient set assembly in fluid communication with said delivery arrangement, said patient set assembly comprising a peristaltic pump component and at least one delivery tube for delivering the pressurized fluid to the patient, said peristaltic pump component having a connecting element for fluidically engaging the connecting element of the connector of the delivery arrangement at said port of the pressurizing unit, characterized in that said latching mechanism comprises an elongated flap integral with said connector, and said latching mechanism engages a corresponding port of the pressurizing unit.",
  "claims": [
    "1. An injection system (100) comprising: at least one supply station (105 a; 105 b; 105 c) for supplying a fluid to be injected into a patient's vasculature; a pressurizing unit (140) comprising a motor for pressurizing the fluid received from said at least one supply station (105 a; 105 b; 105 c); a delivery arrangement (135) in fluid communication with said at least one supply station (105 a; 105 b; 105 c), the delivery arrangement (135) comprising a connector (300) having a connecting element (375) and a latching mechanism (380); a patient set assembly (145) in fluid communication with said delivery arrangement (135), said patient set assembly (145) comprising a peristaltic pump component (147) and at least one delivery tube (146) for delivering the pressurized fluid to the patient, said peristaltic pump component (147) having a connecting element (150) for fluidically engaging the connecting element (375) of the connector (300) of the delivery arrangement (135) at a port (151) of the pressurizing unit (140), characterized in that said latching mechanism (380) comprises an elongated flap (381) integral with a connector body portion (370) of said connector (300), and said latching mechanism (380) engages a corresponding port (151) of the pressurizing unit (140).",
    "2. The injection system (100) according to claim 1, characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383).",
    "3. The injection system (100) according to claim 2, characterized in that the elongated flap (381) comprises a bulge element (386) protruding from an external profile of said second curvilinear portion (383).",
    "4. The injection system (100) according to claim 1, characterized in that the elongated flap (381) comprises a free first end (384) for being acted upon by an operator.",
    "5. The injection system (100) according to claim 4, characterized in that the elongated flap (381) comprises a second end (385), opposite to the first end (384), said second end (385) being integral with the connector body portion (370) of said connector (300).",
    "6. The injection system (100) according to claim 5, characterized in that the connector body portion (370) defines a front wall (371) and a rear wall (372), the second end (385) of the elongated flap (381) being integral with said rear wall (372).",
    "7. The injection system (100) according to claim 6, characterized in that the connector (300) comprises a housing (400) for receiving at least one tube of the delivery arrangement (135), said housing (400) being integral with the connector body portion (370).",
    "8. The injection system (100) according to claim 7, characterized in that the housing (400) is integral with the rear wall (372) of the connector body portion (370).",
    "9. The injection system (100) according to claim 7, characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383) and characterized in that a curvature of the second curvilinear portion (383) at least partially matches a curvature of the housing (400).",
    "10. The injection system (100) according to claim 7, characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383) and characterized in that the second curvilinear portion (383) is spaced apart from the housing (400).",
    "11. The injection system (100) according to claim 5, characterized in that the connector body portion (370) defines a front wall (371) and a rear wall (372) and characterized in that the elongated flap (381) comprises a first straight portion (382) and a second curvilinear portion (383) and characterized in that the elongated flap (381) comprises a bulge element (386) protruding from an external profile of said second curvilinear portion (383) and characterized in that a first point (387) from which said bulge element (386) is originated is positioned at a different level with respect to a second point (388) where the second end (385) of the elongated flap (381) is attached to the rear wall (372) of the connector body portion (370).",
    "12. The injection system (100) according to claim 11, characterized in that, with reference to a base component (373) of the connector body portion (370), said first point (387) is positioned at a height greater than a height of said second point (388).",
    "13. The injection system (100) according to claim 4, characterized in that, in proximity of said free first end (384), an outer profile of said elongated flap (381) is provided with a gripping surface (389).",
    "14. The injection system (100) according to claim 1, characterized in that the delivery arrangement (135) comprises at least one supporting element (600) which is made of a single component and which has a substantially U-shape configuration in cross-section.",
    "15. The injection system (100) according to claim 1, characterized in that the connector (300) comprises a housing (400) for receiving at least one tube of the delivery arrangement (135), said housing (400) being integral with the connector body portion (370)."
  ],
  "description_excerpt": "The present disclosure relates to the field of medical devices. More specifically, the present disclosure relates to injection systems for delivering a medical fluid to a patient.\n\nThe background of the present disclosure is hereinafter introduced with the discussion of techniques relating to its context. However, even when this discussion refers to documents, acts, artifacts and the like, it does not suggest or represent that the discussed techniques are part of the prior art or are common general knowledge in the field relevant to the present disclosure.\n\nThe injection of fluids into patients is commonplace in several medical procedures. For example, a contrast agent (or contrast medium) may be injected, possibly along with a saline solution, to enhance contrast of target (body) features (for example, human body's structures or organs) within the patients in scan examinations thereof. Particularly, in imaging applications (wherein a visual representation of the interior of the patients is created in a non-invasive way without turning to surgery techniques) the use of the contrast agent makes the target features more conspicuous. As a result, target features that would otherwise be less distinguishable from other nearby features (for example, surrounding tissues) are highlighted. This significantly facilitates the task of clinicians in diagnostic applications, and particularly the identification and/or characterization of lesions, the monitoring of their evolution or response to medical treatments.",
  "cpc": [
    "A61M 5/14228",
    "A61M 2039/0009",
    "A61M 2039/0027",
    "A61M 2039/1016",
    "A61M 2205/50",
    "A61M 2205/502",
    "A61M 39/10",
    "A61M 39/1011",
    "A61M 39/105",
    "A61M 5/007",
    "A61M 5/1407",
    "A61M 5/1408",
    "A61M 5/1413",
    "A61M 5/1418"
  ],
  "ipc": [
    "A61M 39/10",
    "A61M 5/00",
    "A61M 5/14",
    "A61M 5/142",
    "A61M 1/14"
  ],
  "assignees": [
    "ACIST Medical Systems Inc"
  ],
  "inventors": [
    "Pierre-Yves Chassot",
    "Francois VULLIET"
  ],
  "filing_date": "2019-07-23",
  "publication_date": "2024-11-05",
  "grant_date": "2024-11-05",
  "priority_date": "2018-07-25",
  "application_number": "US-201917262451-A",
  "family_id": "63047191",
  "cited_by_count": 14,
  "citations": [
    "US20090105629A1",
    "US20150209515A1",
    "US20140208251A1",
    "US20150174320A1",
    "US20160331891A1"
  ]
}

Record 328 of 8,000 in Patents full text (MLC-0201). Request the full dataset.